Mini Review
Published on 05 Dec 2025
Next-generation vaccines against bacterial pathogens: mRNA and beyond
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1709794
- 3,266 views
Type at least 3 characters
3,192 articles
articles
Original Research
Published on 03 Dec 2025
Evaluation of anti-tetanus IgG antibody levels and influencing factors in patients undergoing hemodialysis
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1678676
- 1,114 views
Original Research
Published on 03 Dec 2025
Variant-adapted COVID-19 vaccine boosters enhance humoral immunity and limit IgG4 accumulation in solid cancer patients
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1699177
- 1,619 views
Original Research
Published on 01 Dec 2025
In silico design of novel precision vaccine targeting sclerostin epitopes for osteoporosis prevention and treatment
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1644437
- 1,698 views
- 1 citation
Original Research
Published on 27 Nov 2025
Establishment of rapid saturation mutagenesis and screening methods for improving the neutralizing activity of monoclonal antibodies
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1722831
- 1,263 views
Correction
Published on 26 Nov 2025
Correction: Synergistic nano-vaccine strategy for comprehensive activation of adaptive and innate immunity against Staphylococcus aureus infection
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1740490
- 636 views
Original Research
Published on 26 Nov 2025
Synthetic DNA co-immunization with vaccine-aligned common consensus nucleoprotein and hemagglutinin protects mice against lethal influenza infection with a single immunization
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1632121
- 2,096 views
Original Research
Published on 25 Nov 2025
Harnessing mRNA technology against Fasciola hepatica: Immunological insights from a fatty acid binding protein vaccine
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1693674
- 1,794 views
Original Research
Published on 21 Nov 2025
Optimized multi-epitope neoantigen human cytomegalovirus vaccine based on adenovirus vectors elicits potent antiviral immunity
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1658220
- 2,865 views
- 1 citation
Original Research
Published on 21 Nov 2025
Immunization with the M12-N, M12-C, and M12-N+C fusion peptides derived from the M12 protein elicited varying levels of protective immune responses against multiple serotypes of group A Streptococcus
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1636591
- 999 views
Review
Published on 21 Nov 2025
Unique antibodies across the animal kingdom (birds, camelids, and sharks): therapeutic potential against human respiratory viral infections
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1723343
- 1,635 views
Review
Published on 19 Nov 2025
Yeast vaccine production platform for human and animal infectious diseases
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1697177
- 2,953 views
Correction
Published on 19 Nov 2025
Correction: An oral M-cell targeted Lactococcus lactis vaccine against Echinococcus multilocularis infection
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1741460
- 471 views
Original Research
Published on 19 Nov 2025
A multi-epitope vaccine incorporating adhesin-derived antigens protects against Mycobacterium tuberculosis infection and dissemination
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1707471
- 1,770 views
- 1 citation
Original Research
Published on 18 Nov 2025
Heterologous ORFV–Ad26 vaccination broadens antibody breadth and amplifies cellular immunity against SARS-CoV-2 spike
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1715442
- 1,151 views
- 1 citation
Original Research
Published on 18 Nov 2025
Development and implementation of a gyrolab-based generic anti-drug antibody assay for antibody-drug conjugates in cynomolgus monkey studies
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1711816
- 1,392 views
Original Research
Published on 17 Nov 2025
Utilisation of monoclonal antibodies in the single radial immunodiffusion assay to determine potency and stability for seasonal and pandemic influenza vaccines
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1696191
- 2,081 views
Clinical Trial
Published on 14 Nov 2025
Safety, tolerability, and immunogenicity of a DNA-based vaccine (INO-4700) against Middle East respiratory syndrome coronavirus: phase 2a study in healthy volunteers
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1662923
- 2,551 views
Clinical Trial
Published on 14 Nov 2025
Immunogenicity and safety of an Escherichia coli-produced 9-valent human papillomavirus vaccine (types 6/11/16/18/31/33/45/52/58) in healthy Chinese women aged 20–45 years: a single-center, randomized, observer-blinded, positive controlled phase 2 clinical trial
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1706662
- 2,004 views
- 1 citation
Editorial
Published on 11 Nov 2025
Editorial: Vaccines and therapeutics utilizing new adjuvants and potential inhibitors to target emerging infectious diseases
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1716739
- 1,090 views
Original Research
Published on 11 Nov 2025
Immunization with outer membrane vesicles drived Proteus mirabilis protects mice against bacteria-induced lethality
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1688837
- 1,596 views
Original Research
Published on 11 Nov 2025
Multi-antigen MVA-vectored SARS-CoV-2 vaccine, GEO-CM04S1, induces cross-protective immune responses to ancestral and Omicron variants
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1694699
- 2,201 views
Original Research
Published on 11 Nov 2025
Promiscuous class II-binding SARS-CoV-2-nuc derived vaccine-peptide induced extensive conventional, innate and unconventional T cell responses
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1676455
- 2,021 views
Original Research
Published on 11 Nov 2025
Influence of heparin-based anticoagulants on antibiotic therapy
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1708169
- 1,449 views